These explanations are designed to help patients and families orient themselves before speaking with a research coordinator or reviewing a study in more detail.
Do I have to pay to participate in a clinical trial?
In most cases, study-related procedures, treatments, and visits are provided at no cost to participants. Standard medical care that falls outside the trial protocol may still be billed normally. It is important to discuss cost details with the research team and your insurance provider before enrolling.
Can I withdraw from a trial after I've already enrolled?
Yes. Participation in any clinical trial is entirely voluntary, and you may withdraw at any time and for any reason without penalty. Withdrawing will not affect your access to standard medical care or any other benefits you are entitled to.
What is a placebo and will I receive one?
A placebo is an inactive substance used as a comparison in some randomized trials. Not all trials use placebos — and you will always be told in the informed consent document whether a placebo is part of the study design. Receiving a placebo is never hidden from participants in ways that would put them at risk without disclosure.
How is my personal health information protected?
Research teams are required to follow HIPAA regulations and institutional data privacy policies. Your information is used only for purposes described in the consent document, and any published results are reported in aggregate — not in ways that identify individual participants.
How long does a clinical trial typically last?
Duration varies widely depending on the phase and purpose of the study. Some trials span a few weeks; others continue for years. The informed consent document will describe the expected length of participation and what each stage involves.
What happens if I experience a side effect during the trial?
Research teams are required to monitor participant safety continuously. If you experience any adverse effects, you should report them to your study coordinator immediately. Trials have safety monitoring boards that review data regularly, and studies can be paused or stopped if emerging information warrants it.